Glutathione peroxidase, glutathione reductase, Cu-Zn superoxide dismutase activities, glutathione, nitric oxide, and malondialdehyde concentrations in serum of patients with chronic lymphocytic leukemia

被引:68
作者
Bakan, N [1 ]
Taysi, S
Yilmaz, Ö
Bakan, E
Kuskay, S
Uzun, N
Gündogdu, M
机构
[1] Ataturk Univ, Dept Biochem, Sch Med, TR-25240 Erzurum, Turkey
[2] Ataturk Univ, Dept Internal Med, Sch Med, TR-25240 Erzurum, Turkey
关键词
malondialdehyde; glutathione; glutathione peroxidase; superoxide dismutase; nitric oxide;
D O I
10.1016/j.cccn.2003.08.013
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Background: Chronic lymphocytic leukemia (CLL) is a rare neoplasm that comprises a substantial proportion of all leukemias in middle-aged persons and is the most common type among elderly persons. The major causes are not known nor is there a detailed understanding about how the elusive origin(s) may relate to clinical expression, basic biological mechanisms, or pathogenesis. Methods: Glutathione peroxidase (GSH-Px), glutathione reductase (GRD), Cu-Zn superoxide dismutase (Cu-Zn SOD) activities, glutathione (GSH), nitric oxide (NO.), and malondialdehyde (NIDA) concentrations were measured in serum of patients with CLL and a healthy control group. Results: Serum GSH-Px, Cu-Zn SOD activities, GSH concentration were lower in patients with CLL while serum NO. and MDA concentrations were higher in these patients compared with the control group. Serum GRD activity was not statistically significant in patients with CLL compared with the control. However, there was no statistically significant difference in the parameters on the basis of stages in these patients. Serum GSH concentration negatively correlated with serum MDA (r=30.63, p<0.05) and NO center dot concentrations (r=0.72, p<0.05) in patients with advanced stage (III + IV). However, no other correlation could be found among the parameters in healthy controls and patients with CLL Conclusions: There is significant changes in antioxidant defense system in CLL cases, which may lead to enhanced action of oxygen radical, resulting in lipid peroxidation. (C) 2003 Elsevier B.V. All rights reserved.
引用
收藏
页码:143 / 149
页数:7
相关论文
共 58 条
  • [1] Nitric oxide biosynthesis and malondialdehyde levels in advanced breast cancer
    Alagöl, H
    Erdem, E
    Sancak, B
    Turkmen, G
    Camlibel, M
    Bugdayci, G
    [J]. AUSTRALIAN AND NEW ZEALAND JOURNAL OF SURGERY, 1999, 65 (09): : 647 - 650
  • [2] Arivazhagan K, 1997, CELL BIOCHEM FUNCT, V15, P15
  • [3] Nitric oxide levels and lipid peroxidation in plasma of patients with gastric cancer
    Bakan, E
    Taysi, S
    Polat, MF
    Dalga, S
    Umudum, Z
    Bakan, N
    Gumus, M
    [J]. JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2002, 32 (05) : 162 - 166
  • [4] BENNETT JC, 1996, CECIL TXB MED, P931
  • [5] BEUTLER E, 1985, J LAB CLIN MED, V105, P581
  • [6] Metabolic oxidative stress activates signal transduction and gene expression during glucose deprivation in human tumor cells
    Blackburn, RV
    Spitz, DR
    Liu, X
    Galoforo, SS
    Sim, JE
    Ridnour, LA
    Chen, JC
    Davis, BH
    Corry, PM
    Lee, YJ
    [J]. FREE RADICAL BIOLOGY AND MEDICINE, 1999, 26 (3-4) : 419 - 430
  • [7] BORIES PN, 1995, CLIN CHEM, V41, P904
  • [8] CHESON BD, 1993, CHRONIC LYMPHOID LEU, P33
  • [9] Nitric oxide in patients with transitional bladder cancer
    Eiján, AM
    Piccardo, I
    Riveros, MD
    Sandes, EO
    Porcella, H
    Jasnis, MA
    De Lustig, ES
    Malagrino, H
    Pasik, L
    Casabé, AR
    [J]. JOURNAL OF SURGICAL ONCOLOGY, 2002, 81 (04) : 203 - 208
  • [10] FAIRBANKS VF, 1999, TIETZ TXB CLIN CHEM, P1990